John D Quisel Gemini Therapeutics, Inc. (GMTX) insider trading activity
John D Quisel is Chief Executive Officer of Gemini Therapeutics, Inc. . Currently has a direct ownership of 82,065 shares of GMTX, which is worth approximately $2 Million. The most recent transaction as insider was on Dec 31, 2024, when has been sold 10,000 shares (Common Stock) at a price of $1.01 per share, resulting in proceeds of $10,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
82.1K
13.88%
3M change
18.82%
12M change
Total Value Held
$2 Million
John D Quisel Transaction History
Also insider at
JDQ
John D Quisel
Chief Executive Officer
Watertown, MA